Solvay Sa · EURONEXT:SOLB

Solvay Sa — Investor Presentation (November 2003)

18 slides from Solvay Sa's investor presentation, November 2003

  1. Slide 1: Solvay Group presentation: Solvay at a glance

    Solvay Group presentation Solvay at a glance November 2003

  2. Slide 2: Solvay at a glance: 140 years of future

    Solvay at a glance « 140 years of future » © 2003, SOLVAY S.A November 2003

  3. Slide 3: Solvay history

    SOLVAY AT A GLANCE Solvay history 140 years of development major Limestone Salt Petroleum Kali Chemie pharmaceutical Feedstocks (1952) acquisitions Soda Ash Electrolysis DUPHAR (1866) (1898) 1980 REID ROWELL Hydrogen (USA) 1986 Peroxide (1958) UNIMED (USA) Acquisition of the Ausimont Group in 2002 1

  4. Slide 4: Solvay today

    SOLVAY AT A GLANCE Solvay today 140 years of future ü An international presence and worldwide leadership ü Active in 4 sectors : Pharmaceuticals, Chemicals, Plastics and Processing ü Focusing on stronger growth in Pharmaceuticals and Specialties and competitive Essentials ü Serving a diversified cus

  5. Slide 5: Solvay in brief in 2002

    SOLVAY AT A GLANCE Solvay in brief in 2002 w 496 EUR million net earnings : a record w 1100 EUR million cash flow : a record w 85% of sales in products where Solvay ranks amongst the world leaders w 64% of 2002 EBIT are realized by the Specialties and Pharmaceuticals w 95% of sales are realized outs

  6. Slide 6: Solvay today: an international presence

    SOLVAY AT A GLANCE Solvay today an international presence about 30,300 employees sales of about EUR 7.9 bn in more than 50 countries Europe 62% The Americas Asia-Pacific 31% 7% (USA : 23%) Industrial/Commercial Presence Export (in % of 2002 sales) PPPT 0000 6 © 2003, SOLVAY S.A November 2003

  7. Slide 7: An international presence: sales by region

    SOLVAY AT A GLANCE An international presence breakdown of sales by region Nafta European Union 26% 55% The Americas Europe 31% 62% Other European countries Mercosur 7% 5% Africa Asia-Pacific Middle-East 7% 1% In % of 2002 sales (EUR 7,918 M) PPPT 0000 7 © 2003, SOLVAY S.A November 2003

  8. Slide 8: An international presence: employees by region

    SOLVAY AT A GLANCE An international presence breakdown of employees by region European Union 72% Nafta France 16% 17% Germany 17% Benelux 15% Spain/ Portugal 8% Italy 11% UK 3% Others 2% Mercosur 4% Other European Asia-Pacific countries 3% 4% In % of total employees as of Jan. 1, 2003 (30,302 people

  9. Slide 9: Serving a diversified customer base

    SOLVAY AT A GLANCE Serving a diversified customer base (% of 2002 sales) 1. Human health 25% 2. Construction and civil engineering 13% 3. Automotive industry 13% 4. Chemical industry 10% 5. Glass industry 7% 6. Consumer goods 6% 7. Water and the environment 4% 8. Electricity and electronics 4% 9. De

  10. Slide 10: Greater clarity and empowerment

    SOLVAY AT A GLANCE Greater clarity and empowerment • 4 sectors / 17 Strategic Business Units : the most visible base of the Group • Creation of 16 Competence Centres and Business Support centres • Competence Centres (CC), each with a strategic role and global responsibility in its particular field •

  11. Slide 11: Solvay's portfolio

    SOLVAY AT A GLANCE Solvay’s portfolio Pharmaceuticals, Specialties and Essentials ü PHARMACEUTICALS w Hormone Replacement Therapy, Gastroenterology, Cardiology, Psychiatry ü SPECIALTIES w Chemicals : Fluorinated products, advanced functional minerals, caprolactones , ultra-pure H2O2 and disinfectant

  12. Slide 12: Solvay's portfolio: present in sectors

    SOLVAY AT A GLANCE Solvay’s portfolio Present in 4 sectors PHARMACEUTICALS Gastroenterology, Hormone Therapies, Psychiatry, Cardiology CHEMICALS w Essentials (soda ash, caustic soda, hydrogen peroxyde, persalts, barium and strontium carbonates) with leaderships and competitive advantages w Specialti

  13. Slide 13: Present in four sectors: sales and EBIT

    SOLVAY AT A GLANCE Present in four sectors Sales and EBIT by sector in 2002 Total 2002 sales : EUR 7,918 M Total 2002 EBIT : EUR 772 M Chemicals Pharmaceuticals Chemicals Pharmaceuticals 32% 24% 30% 30 % (EUR 2,636 M) (EUR 1,863 M) (EUR 230 M) (EUR 235 M) Plastics Processing Plastics Processing 25%

  14. Slide 14: Equal contribution of Chemicals, Plastics and Pharmaceuticals

    SOLVAY AT A GLANCE Equal contribution of Chemicals, Plastics and Pharmaceuticals In% of 2002 EBIT (EUR 772 M) Chemicals Pharmaceuticals 30% 30% (EUR 235 M) (EUR 230 M) Plastics Processing 30% 10% (EUR 234 M) (EUR 73 M) PPPT 0000 (in B GAAP) 14 © 2003, SOLVAY S.A November 2003

  15. Slide 15: Present in four sectors: evolution of performances

    SOLVAY AT A GLANCE Present in four sectors Evolution of performances by sector in 2002 éPHARMACEUTICALS ê CHEMICALS é é PLASTICS éPROCESSING (30% of 2002 EBIT) (30% of 2002 EBIT) wSales : (31% of 2002 EBIT) w Sales : -26% (9% of 2002 EBIT) total : +5% in EUR w Sales : -4% w Integration of wSales : -

  16. Slide 16: Present in four sectors: employees by sector

    SOLVAY AT A GLANCE Present in four sectors Breakdown of employees by sector Chemicals Pharmaceuticals 35% 25% 10,712 persons 7,557 persons Plastics Processing 19% 21% 5,712 persons 6,321 persons PPPT 0000 16 © 2003, SOLVAY S.A November 2003

  17. Slide 17: Visit our Internet site for Investors

    Visit our Internet site specifically designed for Investors www.solvay-investors.com and become member of our Shareholders’ Club PPPT 0000 17 © 2003, SOLVAY S.A November 2003

  18. Slide 18: Forward-looking statements disclaimer

    “To the extent that any statements made in this presentation contain contain information that is not historical, these statements are essentially essentially forward- forward -looking. The achievement of forward- forward -looking statements contained in this presentation is subject to risks and unce

Solvay — Investor Presentation (November 2003) on 6ix